Recall Register

Food, drugs, devices › Mylan Pharmaceuticals Inc.

Food recall: DrNatura Flora Protect¿ Probiotics

FDA enforcement event 81774 · Class II · initiated 10 Dec 2018 · status Terminated · terminated 22 Oct 2019

FoodVoluntary: Firm initiated2 product recordsMorgantown, WV

Mylan Pharmaceuticals Inc. (Morgantown, WV) initiated this food recall on 10 Dec 2018; FDA lists 2 product records under event 81774, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 56% of the 578 food enforcement events initiated in 2018 carry the same class.

Status: Terminated, terminated 22 Oct 2019. Initiation: voluntary: firm initiated. Mylan Pharmaceuticals Inc. has 55 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Mylan Pharmaceuticals Inc., Morgantown, WV.

Reason for recall

"Mylan Consumer Healthcare has decided to initiate recall of the following products : Item# 46017-088-04 DrNatura Flora Protect Probiotics lot 3020068 Expiry Mar 2019 and Item# 46017-088-18 DrNatura Toxinout Kit lot 005983-001 Expiry Dec 2018 . The products are being recalled due to undeclared soy allergen statement."

Distribution

"US Market"

Product records

Recall numberProductQuantityClassStatusReport date
F-0858-2019DrNatura Flora Protect¿ Probiotics2378 BottlesClass IITerminated20 Feb 2019
F-0859-2019DrNatura Toxinout Kit Broad Spectrum Detoxification Program800 KitsClass IITerminated20 Feb 2019

Context

56%of 2018 food events are Class II578 events that year
2product records in this eventfirm median: 1
55events on this register for the firm

Other enforcement events for Mylan Pharmaceuticals Inc.

InitiatedProduct (first record)TypeClassRecords
26 Aug 2026Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, ManufacturedDrugClass II1
17 Aug 2026Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., MorgantoDrugClass II1
24 Jul 2026Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., ManufactDrugClass II1
2 Jul 2026Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: MDrugClass II1
24 Feb 2026Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: MyDrugClass II1
25 Feb 2025Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 265DrugClass II1
5 Jul 2022Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packagDrugClass I1
12 Apr 2022Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside DrugClass I1
7 Apr 2022Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, MorgaDrugClass II1
1 Apr 2022Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., MorgaDrugClass II1

All 55 events for Mylan Pharmaceuticals Inc.

Questions and answers

Why was this food recalled?

FDA's record gives the reason for recall as: "Mylan Consumer Healthcare has decided to initiate recall of the following products : Item# 46017-088-04 DrNatura Flora Protect Probiotics lot 3020068 Expiry Mar 2019 and Item# 46017-088-18 DrNatura Toxinout Kit lot 005983-001 Expiry Dec 2018 . The products are being recalled due to undeclared soy allergen statement."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Market"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 22 Oct 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA food enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.